We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

133 hedge funds and large institutions have $730M invested in Momenta Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 48 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $17.9M | Put options by funds: $9.68M

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

23% more capital invested

Capital invested by funds: $591M → $730M (+$139M)

6% more funds holding

Funds holding: 126 → 133 (+7)

19% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 48

Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
3.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
39
Reduced
48
Closed
18
Calls
$17.9M
Puts
$9.68M
Net Calls
+$8.22M
Net Calls Change
+$3.47M

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$47.4M
2
ACM
Apex Capital Management
Ohio
+$10.1M
3
PC
PointState Capital
New York
+$5.88M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$3.5M
5
MAA
Managed Account Advisors
New Jersey
+$2.8M

Top Sellers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
-$24M
2
DM
Deerfield Management
New York
-$14.6M
3
State Street
State Street
Massachusetts
-$8.02M
4
Goldman Sachs
Goldman Sachs
New York
-$4.47M
5
IGIM
I.G. Investment Management
Manitoba, Canada
-$4.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
26
STRS Ohio
Ohio
$4.9M -$2.32M -138,090 -33%
TCIM
27
TIAA CREF Investment Management
New York
$4.79M -$82.3K -4,900 -2%
BNP Paribas Asset Management
28
BNP Paribas Asset Management
France
$4.53M +$496K +29,514 +13%
AQR Capital Management
29
AQR Capital Management
Connecticut
$3.99M -$1.32M -78,300 -26%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$3.98M +$116K +6,911 +3%
Goldman Sachs
31
Goldman Sachs
New York
$3.94M -$4.47M -266,162 -54%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$3.92M -$2.15M -127,799 -37%
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$3.69M +$3.5M +208,435 New
Invesco
34
Invesco
Georgia
$3.65M +$1.08M +64,426 +45%
Wellington Management Group
35
Wellington Management Group
Massachusetts
$3.6M -$53.8K -3,200 -2%
Ameriprise
36
Ameriprise
Minnesota
$3.46M +$325K +19,322 +11%
BG
37
BlackRock Group
United Kingdom
$3.39M +$18.2K +1,084 +0.6%
Morgan Stanley
38
Morgan Stanley
New York
$2.98M +$404K +24,043 +17%
MAA
39
Managed Account Advisors
New Jersey
$2.95M +$2.8M +166,667 New
BIM
40
BlackRock Investment Management
Delaware
$2.82M -$51.4K -3,061 -2%
U
41
UBS
Switzerland
$2.81M -$511K -30,419 -16%
GC
42
Guggenheim Capital
Illinois
$2.81M +$2.67M +158,638 New
PP
43
PDT Partners
New York
$2.67M -$379K -22,530 -13%
WHI
44
William Harris Investors
Illinois
$2.48M – – –
SGA
45
Sector Gamma AS
Norway
$2.42M -$840K -50,000 -27%
MSA
46
Mason Street Advisors
Wisconsin
$2.36M +$2.13M +126,555 +1,871%
Charles Schwab
47
Charles Schwab
California
$2.33M -$1.12M -66,364 -33%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$2.29M +$430K +25,615 +25%
GACM
49
Green Arrow Capital Management
New York
$2.21M +$2.1M +125,000 New
Citadel Advisors
50
Citadel Advisors
Florida
$2.19M -$1.17M -69,437 -36%
1
2
3 4 5

MNTA Hedge Fund Activity: Q4 2013 in Review

133 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2013, worth a combined $730M — up 23% from $591M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MNTA positions and 18 closed out — a net gain of 7 holders — while 39 added to existing stakes and 48 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $47.4M. The largest seller was Bridger Management, exiting entirely with an estimated $24M sold.

  • 133 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2013, up from 126 in Q3 2013.
  • Funds reported $730M of Momenta Pharmaceuticals, Inc. stock for Q4 2013, up 23% quarter-over-quarter.
  • 25 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2013 and 18 closed out, a net change of +7 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $47.4M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2013 was Bridger Management, an estimated $24M sold.

Based on aggregated 13F filings for Q4 2013.